-
-
-
-
-
-
-
Merck (MRK) PT Raised to $145 at Guggenheim
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Merck (MRK)
-
-
-
-
-
-
-
Merck (MRK) PT Raised to $140 at Guggenheim, 'continue to see MRK as one of our Top Picks'
-
-
-
-
-
-
-
Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3
-
-
-
-
-
-
-
Morning Bid: Dollar rejuvenated
-
-
-
-
-
-
-
Merck (MRK) Tops Q1 EPS by 8c; updates guidance
-
-
-
-
-
-
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
-
1,223,217 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

